# Y-3 for Injection in the Treatment of Acute Ischemic Stroke

> **NCT06517173** · PHASE3 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 998 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Y-3 for injection
- **DRUG:** Placebo control group

## Key facts

- **NCT ID:** NCT06517173
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 998 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06517173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06517173, "Y-3 for Injection in the Treatment of Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06517173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*